Search For "astra"
Brazil's COVID-19 vaccine volunteer dies, authorities say trial to cont
Updated : 5 years, 4 months ago IST
Brasilia [Brazil], October 22 (ANI): A volunteer in Brazil's clinical trial of COVID-19 vaccine being developed by AstraZeneca and Oxford University has died, the Brazilian health agency Anvisa announced on Wednesday while adding that the trial will continue.
Read More
'Dashobhuja' short film on Maa Durga by Spagia Foundation draws the Who's
Updated : 5 years, 4 months ago IST
Jaipur (Rajasthan) India, Oct 19 (ANI/ NewsVoir): A short musical film "Dashobhuja" (the ten-armed Goddess) by Spagia Foundation has drawn the who's who of the performing arts and film world to highlight the ten astras or weapons held by Maa Durga in each hand and its deep spiritual meani
Read More
Trudeau announces vaccine pact as Canada surpasses 150,000 Covid cases
Updated : 5 years, 5 months ago IST
Toronto [Canada], September 26 (ANI/Sputnik): Canadian Prime Minister Justin Trudeau on Friday announced that his government has entered into an agreement with British pharmaceutical giant AstraZeneca to procure 20 million doses of its coronavirus vaccine.
Read More
Serum Institute all set to begin phase 3 trials of Covid-19 vaccine
Updated : 5 years, 5 months ago IST
Pune (Maharashtra) [India], September 19 (ANI): Serum Institute of India (SII) is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford University at Sassoon General Hospital in Pune, the hospital administration said on Saturday.
Read More
DCGI gives nod to Serum Institute to restart phase 2,3 trials for COVID-19
Updated : 5 years, 6 months ago IST
New Delhi [India], September 16 (ANI): The Drugs Controller General of India (DCGI) has allowed Serum Institute of India (SII) to restart its phase two and three clinical trials for COVID-19 vaccine after the pharma major submitted the recommendations of the Data Safety Monitoring Board (DSM
Read More
Equity indices trade higher, IT stocks shine
Updated : 5 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 14 (ANI): Equity benchmark indices traded firm during early hours on Monday on the back of positive global cues as hopes of a coronavirus vaccine were rekindled after AstraZeneca resumed its phase three trial.
Read More
Suspension of AstraZeneca COVID-19 vaccine trials showed fallacy of approa
Updated : 5 years, 6 months ago IST
Moscow [Russia], September 13 (ANI): Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev on Saturday said that temporary suspension of AstraZeneca COVID-19 vaccine candidate trials clearly showed the "fallacy of the approach" when countries "exclusively rely on novel and untested platf
Read More
Serum Institute to resume COVID-19 vaccine trials in India after DCGI nod
Updated : 5 years, 6 months ago IST
New Delhi [India], September 12 (ANI): Hours after clinical trials for AstraZeneca and Oxford University coronavirus vaccine resumed on Saturday in the UK, pharma major Serum Institute of India (SII) said it will resume the trials in India once Drugs Controller General of India (DCGI) gives
Read More
Oxford vaccine phase 3 trials resume after halt over safety concerns
Updated : 5 years, 6 months ago IST
London [UK], September 12 (ANI): The third phase of AstraZeneca's coronavirus vaccine trial has resumed in the UK, days after it was halted over safety concerns.
Read More
AstraZeneca CEO says COVID-19 vaccine may be ready by end of year despite
Updated : 5 years, 6 months ago IST
London [UK], September 10 (ANI/Sputnik): AstraZeneca CEO Pascal Soriot on Wednesday expressed hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company would be ready by the end of 2020 or early 2021, despite having to pause clinical trials.
Read More
DCGI sends show cause notice to Serum Institute for not pausing trial of
Updated : 5 years, 6 months ago IST
New Delhi [India], September 9 (ANI): The Drugs Regulator General of India (DCGI) has issued a show-cause notice to pharma giant Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts
Read More
Oxford COVID-19 vaccine trials not paused in India, clarifies Serum Instit
Updated : 5 years, 6 months ago IST
New Delhi [India], September 9 (ANI): After AstraZeneca suspended the trials of COVID-19 vaccine in the UK, Indian pharmaceutical giant Serum Institue of India (SII) on Wednesday clarified that testing of the possible vaccine candidate in India is ongoing and has not faced any issue so far.
Read More